PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 62 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,703 | -34.6% | 3,140 | -4.8% | 0.00% | – |
Q2 2023 | $14,837 | -86.0% | 3,297 | -78.5% | 0.00% | – |
Q1 2022 | $106,000 | -48.3% | 15,316 | -7.0% | 0.00% | – |
Q4 2021 | $205,000 | -51.5% | 16,470 | +21.8% | 0.00% | -100.0% |
Q3 2021 | $423,000 | -1.2% | 13,524 | -9.5% | 0.00% | 0.0% |
Q2 2021 | $428,000 | -34.0% | 14,939 | -0.1% | 0.00% | 0.0% |
Q1 2021 | $648,000 | -34.8% | 14,947 | +7.6% | 0.00% | 0.0% |
Q4 2020 | $994,000 | – | 13,888 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 10,039,691 | $69,274,000 | 1.12% |
Baker Brothers Advisors | 10,123,824 | $69,854,000 | 0.40% |
HHLR ADVISORS, LTD. | 583,333 | $4,025,000 | 0.08% |
Rock Springs Capital Management LP | 368,959 | $2,546,000 | 0.06% |
PDT Partners, LLC | 71,822 | $496,000 | 0.04% |
Virtus ETF Advisers LLC | 13,048 | $90,000 | 0.04% |
Corton Capital Inc. | 10,918 | $75,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 23,201 | $160,000 | 0.02% |
OCCUDO QUANTITATIVE STRATEGIES LP | 24,238 | $167,000 | 0.01% |
IndexIQ Advisors LLC | 56,750 | $392,000 | 0.01% |